Clinical Trial

Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regimen

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Dose\_dense Capecitabine Schedule in colorectal cancers
Trial Details
NCT Number NCT07215936
Lead Sponsor Sohag University
Conditions Colorectal Cancer
Enrollment 100 participants
Start Date 2025-09-25
Primary Completion 2027-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2025-10-14